Cezary Wójcik

6PUBLICATIONS
23CO-AUTHORS
Liquid biopsiesCardiology (incl. cardiovascular diseases)Proteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 30, 2026
Lipoprotein (a) Testing and Changes in Lipid-Lowering Therapy in Patients With ASCVD: Findings From the cvMOBIUS-2 Registry.

|Feb 20, 2026
Variation in Lipid Management for Atherosclerotic Cardiovascular Disease Across US Health Systems.

Nishant P Shah, Eric D Peterson, Peter Shrader

|Jun 19, 2024
Cellular Distribution and Ultrastructural Changes in HaCaT Cells, Induced by Podophyllotoxin and Its Novel Fluorescent Derivative, Supported by the Molecular Docking Studies.

Piotr Strus, Karol Sadowski, Julia Kostro

|Nov 22, 2023
LOGAN-CV: A Prospective Study of a Multifaceted Intervention Targeting United States Clinicians to Improve Guideline-Based Management of Lipid-Lowering Therapy.

J Nikki McKoy, Bethany A Kalich, Laura Greene

|Apr 04, 2020
Emerging lipid lowering agents targeting LDL cholesterol.

Cezary Wójcik

|Sep 08, 2017
Incorporation of PCSK9 inhibitors into prevention of atherosclerotic cardiovascular disease.

Cezary Wójcik

Pageof 1

Frequent Collaborators

2 joint publications

Ann Marie Navar

2 joint publications

Nikki Freeman

2 joint publications

Nishant P Shah

2 joint publications

Eric D Peterson